Literature DB >> 21922228

Spinophilin is required for normal morphology, Ca(2+) homeostasis and contraction but dispensable for β-adrenergic stimulation of adult cardiomyocytes.

Daria Petzhold1, André C da Costa-Goncalves, Volkmar Gross, Ingo Morano.   

Abstract

Spinophilin (SPN) is a ubiquitously expressed scaffolding protein that interacts through several binding modules with a variety of target proteins. Thus, SPN bundles F-actin, targets protein phosphatase 1 to the ryanodine receptor, and targets regulators of G-protein signaling to G-protein coupled receptors in cardiomyocytes. In this work we studied the role of SPN on cardiomyocyte morphology, function, and β-adrenergic responsiveness using a homozygous SPN knock-out mouse model (SPN-/-). We show that spinophilin deficiency significantly (1) reduced cardiomyocyte length, (2) increases both Ca(2+) amplitude and maximal rate of Ca(2+) rise during systole, and (3) decreased shortening amplitude and maximal rate of shortening, while (4) β-adrenergic stimulation remained intact. Our data suggest that spinophilin is an upstream regulator required for normal growth and excitation-contraction coupling, but is dispensable for β-adrenergic stimulation of adult cardiomyocytes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21922228     DOI: 10.1007/s10974-011-9259-4

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  19 in total

1.  Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines.

Authors:  P B Allen; C C Ouimet; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Modulation of CICR has no maintained effect on systolic Ca2+: simultaneous measurements of sarcoplasmic reticulum and sarcolemmal Ca2+ fluxes in rat ventricular myocytes.

Authors:  A W Trafford; M E Díaz; G C Sibbring; D A Eisner
Journal:  J Physiol       Date:  2000-01-15       Impact factor: 5.182

Review 3.  Protein dephosphorylation and the intracellular control of the cell number.

Authors:  N Berndt
Journal:  Front Biosci       Date:  1999-01-01

Review 4.  Spinophilin: from partners to functions.

Authors:  D Sarrouilhe; A di Tommaso; T Métayé; V Ladeveze
Journal:  Biochimie       Date:  2006-05-17       Impact factor: 4.079

5.  Enhanced hypotensive, bradycardic, and hypnotic responses to alpha2-adrenergic agonists in spinophilin-null mice are accompanied by increased G protein coupling to the alpha2A-adrenergic receptor.

Authors:  R Lu; Y Chen; C Cottingham; N Peng; K Jiao; L E Limbird; J M Wyss; Q Wang
Journal:  Mol Pharmacol       Date:  2010-04-29       Impact factor: 4.436

6.  Neurabin-II/spinophilin. An actin filament-binding protein with one pdz domain localized at cadherin-based cell-cell adhesion sites.

Authors:  A Satoh; H Nakanishi; H Obaishi; M Wada; K Takahashi; K Satoh; K Hirao; H Nishioka; Y Hata; A Mizoguchi; Y Takai
Journal:  J Biol Chem       Date:  1998-02-06       Impact factor: 5.157

7.  Spinophilin regulates the formation and function of dendritic spines.

Authors:  J Feng; Z Yan; A Ferreira; K Tomizawa; J A Liauw; M Zhuo; P B Allen; C C Ouimet; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

8.  Binding of the catalytic subunit of protein phosphatase-1 to the ryanodine-sensitive calcium release channel protein.

Authors:  S Zhao; N R Brandt; A H Caswell; E Y Lee
Journal:  Biochemistry       Date:  1998-12-22       Impact factor: 3.162

9.  Role of the multidomain protein spinophilin in blood pressure and cardiac function regulation.

Authors:  Andrey C da Costa-Goncalves; Jens Tank; Ralph Plehm; Andre Diedrich; Mihail Todiras; Maik Gollasch; Arnd Heuser; Maren Wellner; Michael Bader; Jens Jordan; Friedrich C Luft; Volkmar Gross
Journal:  Hypertension       Date:  2008-08-18       Impact factor: 10.190

10.  Inhibitory phosphorylation of PP1alpha catalytic subunit during the G(1)/S transition.

Authors:  C W Liu; R H Wang; M Dohadwala; A H Schönthal; E Villa-Moruzzi; N Berndt
Journal:  J Biol Chem       Date:  1999-10-08       Impact factor: 5.157

View more
  4 in total

1.  Growth differentiation factor (GDF)-15 blocks norepinephrine-induced myocardial hypertrophy via a novel pathway involving inhibition of epidermal growth factor receptor transactivation.

Authors:  Xin-ye Xu; Ying Nie; Fang-fang Wang; Yan Bai; Zhi-zhen Lv; You-yi Zhang; Zi-jian Li; Wei Gao
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

2.  Susceptibility of murine induced pluripotent stem cell-derived cardiomyocytes to hypoxia and nutrient deprivation.

Authors:  Andreja Brodarac; Tomo Šarić; Barbara Oberwallner; Shokoufeh Mahmoodzadeh; Klaus Neef; Julie Albrecht; Karsten Burkert; Matteo Oliverio; Filomain Nguemo; Yeong-Hoon Choi; Wolfram F Neiss; Ingo Morano; Jürgen Hescheler; Christof Stamm
Journal:  Stem Cell Res Ther       Date:  2015-04-23       Impact factor: 6.832

Review 3.  Functional Microdomains in Heart's Pacemaker: A Step Beyond Classical Electrophysiology and Remodeling.

Authors:  Di Lang; Alexey V Glukhov
Journal:  Front Physiol       Date:  2018-11-27       Impact factor: 4.566

Review 4.  Counteracting Protein Kinase Activity in the Heart: The Multiple Roles of Protein Phosphatases.

Authors:  Silvio Weber; Stefanie Meyer-Roxlau; Michael Wagner; Dobromir Dobrev; Ali El-Armouche
Journal:  Front Pharmacol       Date:  2015-11-13       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.